{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:49:17Z","timestamp":1783403357626,"version":"3.54.6"},"reference-count":218,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.nbd.2023.106229","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T12:56:52Z","timestamp":1689253012000},"page":"106229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Purinergic receptors in cognitive disturbances"],"prefix":"10.1016","volume":"185","author":[{"given":"Peter","family":"Illes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Fan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2023.106229_bb0005","first-page":"47","article-title":"Parkinson disease-associated cognitive impairment. Nature reviews","volume":"7","author":"Aarsland","year":"2021","journal-title":"Dis. Prim."},{"key":"10.1016\/j.nbd.2023.106229_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002508","article-title":"Neuronal hyperactivity disturbs ATP microgradients, impairs microglial motility, and reduces phagocytic receptor expression triggering apoptosis\/microglial phagocytosis uncoupling","volume":"14","author":"Abiega","year":"2016","journal-title":"PLoS Biol."},{"key":"10.1016\/j.nbd.2023.106229_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105253","article-title":"Purinergic signaling orchestrating neuron-glia communication","volume":"162","author":"Agostinho","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.nbd.2023.106229_bb0020","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s12035-013-8577-5","article-title":"Loss of P2Y\u2082 nucleotide receptors enhances early pathology in the TgCRND8 mouse model of Alzheimer\u2019s disease","volume":"49","author":"Ajit","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2023.106229_bb0025","first-page":"11858","article-title":"Role of the purinergic P2Y2 receptor in hippocampal function in mice","volume":"24","author":"Alhowail","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2023.106229_bb0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/aur.1901","article-title":"The adenosine A(2A) receptor agonist, CGS 21680, attenuates a probabilistic reversal learning deficit and elevated grooming behavior in BTBR mice","volume":"11","author":"Amodeo","year":"2018","journal-title":"Autism Res."},{"key":"10.1016\/j.nbd.2023.106229_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2022.102331","article-title":"Astrocyte energy and neurotransmitter metabolism in Alzheimer\u2019s disease: Integration of the glutamate\/GABA-glutamine cycle","volume":"217","author":"Andersen","year":"2022","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2023.106229_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ynstr.2017.03.003","article-title":"Animal models in psychiatric research: The RDoC system as a new framework for endophenotype-oriented translational neuroscience","volume":"7","author":"Anderzhanova","year":"2017","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.nbd.2023.106229_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119260","article-title":"Reversal of tau-dependent cognitive decay by blocking adenosine A1 receptors: comparison of transgenic mouse models with different levels of tauopathy","volume":"24","author":"Anglada-Huguet","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2023.106229_bb0050","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1476-5381.2011.01303.x","article-title":"P2X4 receptors interact with both P2X2 and P2X7 receptors in the form of homotrimers","volume":"163","author":"Antonio","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2023.106229_bb0055","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neuroscience.2006.07.021","article-title":"Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production","volume":"142","author":"Arendash","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2023.106229_bb0060","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5114\/fn.2013.37702","article-title":"What causes alzheimer\u2019s disease?","volume":"51","author":"Armstrong","year":"2013","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.nbd.2023.106229_bb0065","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0366-18.2019","article-title":"An adenosine A(2A) receptor antagonist improves multiple symptoms of repeated quinpirole-induced psychosis","volume":"6","author":"Asaoka","year":"2019","journal-title":"eNeuro"},{"key":"10.1016\/j.nbd.2023.106229_bb0070","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/hipo.10135","article-title":"Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity","volume":"13","author":"Avital","year":"2003","journal-title":"Hippocampus"},{"key":"10.1016\/j.nbd.2023.106229_bb0075","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1097\/WNR.0b013e3282f262f6","article-title":"Sleep deprivation upregulates A1 adenosine receptors in the rat basal forebrain","volume":"18","author":"Basheer","year":"2007","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2023.106229_bb0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fnins.2017.00021","article-title":"The ATP-gated P2X7 receptor as a target for the treatment of drug-resistant epilepsy","volume":"11","author":"Beamer","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0085","article-title":"Astrocyte adaptation in Alzheimer\u2019s disease: a focus on astrocytic P2X7R","author":"Beltran-Lobo","year":"2022","journal-title":"Essays Biochem."},{"key":"10.1016\/j.nbd.2023.106229_bb0090","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41380-019-0641-8","article-title":"Increased surface P2X4 receptor regulates anxiety and memory in P2X4 internalization-defective knock-in mice","volume":"26","author":"Bertin","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2023.106229_bb0095","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1523\/JNEUROSCI.22-12-04814.2002","article-title":"P2X receptor trafficking in neurons is subunit specific","volume":"22","author":"Bobanovic","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0100","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.neuropharm.2011.01.048","article-title":"Adenosine hypothesis of schizophrenia - opportunities for pharmacotherapy","volume":"62","author":"Boison","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2023.106229_bb0105","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","article-title":"Pharmacology of adenosine receptors: the state of the art","volume":"98","author":"Borea","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2023.106229_bb0110","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1017\/S1461145712000909","article-title":"Pharmacological insights into the role of P2X4 receptors in behavioural regulation: lessons from ivermectin","volume":"16","author":"Bortolato","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.nbd.2023.106229_bb0115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.brainresbull.2011.05.010","article-title":"Selective cognitive impairment in the YAC128 Huntington\u2019s disease mouse","volume":"88","author":"Brooks","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2023.106229_bb0120","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0306-4522(76)90054-3","article-title":"Do some nerve cells release more than one transmitter?","volume":"1","author":"Burnstock","year":"1976","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2023.106229_bb0125","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.pharmthera.2005.08.013","article-title":"Purinergic P2 receptors as targets for novel analgesics","volume":"110","author":"Burnstock","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2023.106229_bb0130","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bies.201100130","article-title":"Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future","volume":"34","author":"Burnstock","year":"2012","journal-title":"BioEssays"},{"key":"10.1016\/j.nbd.2023.106229_bb0135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1113\/expphysiol.2013.071951","article-title":"Purinergic signalling: from discovery to current developments","volume":"99","author":"Burnstock","year":"2014","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.nbd.2023.106229_bb0140","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2174\/0929867321666140706130415","article-title":"Physiopathological roles of P2X receptors in the central nervous system","volume":"22","author":"Burnstock","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.nbd.2023.106229_bb0145","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0306-3623(85)90001-1","article-title":"Is there a basis for distinguishing two types of P2-purinoceptor?","volume":"16","author":"Burnstock","year":"1985","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.nbd.2023.106229_bb0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0074-7696(04)40002-3","article-title":"Cellular distribution and functions of P2 receptor subtypes in different systems","volume":"240","author":"Burnstock","year":"2004","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.nbd.2023.106229_bb0155","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2174\/156802611795347627","article-title":"Adenosine and ATP receptors in the brain","volume":"11","author":"Burnstock","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.nbd.2023.106229_bb0160","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.semcdb.2011.02.023","article-title":"ATP: a ubiquitous gliotransmitter integrating neuron-glial networks","volume":"22","author":"Butt","year":"2011","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.nbd.2023.106229_bb0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jnc.14841","article-title":"The role of adenosine receptors in mood and anxiety disorders","volume":"151","author":"van Calker","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2023.106229_bb0170","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.neuroscience.2014.09.017","article-title":"Pharmacological blockage and P2X7 deletion hinder aversive memories: reversion in an enriched environment","volume":"280","author":"Campos","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2023.106229_bb0175","doi-asserted-by":"crossref","first-page":"14741","DOI":"10.1523\/JNEUROSCI.3728-09.2009","article-title":"Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway","volume":"29","author":"Canas","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0180","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s10072-019-04177-8","article-title":"Late-onset Huntington's disease with 40-42 CAG expansion","volume":"41","author":"Capiluppi","year":"2020","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.nbd.2023.106229_bb0185","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuropharm.2014.01.045","article-title":"The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis","volume":"81","author":"Carmo","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2023.106229_bb0190","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/ejn.12435","article-title":"ATP P2Y1 receptors control cognitive deficits and neurotoxicity but not glial modifications induced by brain ischemia in mice","volume":"39","author":"Carmo","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2021.102139","article-title":"P2X7-deficiency improves plasticity and cognitive abilities in a mouse model of Tauopathy","volume":"206","author":"Carvalho","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2023.106229_bb0200","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/B978-0-12-801022-8.00012-X","article-title":"Adenosine receptor control of cognition in normal and disease","volume":"119","author":"Chen","year":"2014","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.nbd.2023.106229_bb0205","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11302-020-09694-2","article-title":"The belated US FDA approval of the adenosine A(2A) receptor antagonist istradefylline for treatment of Parkinson's disease","volume":"16","author":"Chen","year":"2020","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.nbd.2023.106229_bb0210","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.neuroscience.2013.08.054","article-title":"Enhancement of long-term depression by soluble amyloid \u03b2 protein in rat hippocampus is mediated by metabotropic glutamate receptor and involves activation of p38MAPK, STEP and caspase-3","volume":"253","author":"Chen","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2023.106229_bb0215","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3389\/fncel.2014.00348","article-title":"Connexons and pannexons: newcomers in neurophysiology","volume":"8","author":"Cheung","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2022.151201","article-title":"G-protein coupled purinergic P2Y12 receptor interacts and internalizes Tau(RD)-mediated by membrane-associated actin cytoskeleton remodeling in microglia","volume":"101","author":"Chidambaram","year":"2022","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.nbd.2023.106229_bb0225","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1742-2094-10-95","article-title":"Involvement of glial P2Y\u2081 receptors in cognitive deficit after focal cerebral stroke in a rodent model","volume":"10","author":"Chin","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2023.106229_bb0230","article-title":"Amyloid \u03b2-peptide directly induces spontaneous calcium transients, delayed intercellular calcium waves and gliosis in rat cortical astrocytes","volume":"2","author":"Chow","year":"2010","journal-title":"ASN Neuro"},{"key":"10.1016\/j.nbd.2023.106229_bb0235","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11302-011-9215-1","article-title":"C terminus of the P2X7 receptor: treasure hunting","volume":"7","author":"Costa-Junior","year":"2011","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.nbd.2023.106229_bb0240","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0074-7742(04)59019-0","article-title":"NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia","volume":"59","author":"Coyle","year":"2004","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.nbd.2023.106229_bb0245","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0197-0186(00)00034-6","article-title":"Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors","volume":"38","author":"Cunha","year":"2001","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2023.106229_bb0250","doi-asserted-by":"crossref","first-page":"11915","DOI":"10.1038\/ncomms11915","article-title":"Early synaptic deficits in the APP\/PS1 mouse model of Alzheimer\u2019s disease involve neuronal adenosine A2A receptors","volume":"7","author":"Da Viana Silva","year":"2016","journal-title":"Nat. Commun."},{"issue":"Pt 1","key":"10.1016\/j.nbd.2023.106229_bb0255","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1469-7793.2000.00143.x","article-title":"Direct measurement of adenosine release during hypoxia in the CA1 region of the rat hippocampal slice","volume":"526","author":"Dale","year":"2000","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2023.106229_bb0260","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.expneurol.2006.08.008","article-title":"Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice","volume":"203","author":"Dall\u2019Igna","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2023.106229_bb0265","doi-asserted-by":"crossref","first-page":"34583","DOI":"10.1074\/jbc.M112.400010","article-title":"Ezrin\/radixin\/moesin are required for the purinergic P2X7 receptor (P2X7R)-dependent processing of the amyloid precursor protein","volume":"287","author":"Darmellah","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2023.106229_bb0270","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/tra.12784","article-title":"Microglial remodeling of actin network by Tau oligomers, via G protein-coupled purinergic receptor, P2Y12R-driven chemotaxis","volume":"22","author":"Das","year":"2021","journal-title":"Traffic (Copenhagen, Denmark)"},{"key":"10.1016\/j.nbd.2023.106229_bb0275","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1074\/jbc.M110.200618","article-title":"The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein","volume":"286","author":"Delarasse","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2023.106229_bb0280","first-page":"339","article-title":"New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nature reviews","volume":"11","author":"Deng","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2023.106229_bb0285","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.4103\/0366-6999.162495","article-title":"P2X7 receptor antagonism attenuates the intermittent hypoxia-induced spatial deficits in a murine model of sleep apnea via inhibiting neuroinflammation and oxidative stress","volume":"128","author":"Deng","year":"2015","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.nbd.2023.106229_bb0290","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.4103\/1673-5374.238608","article-title":"Distinguishing normal brain aging from the development of Alzheimer\u2019s disease: inflammation, insulin signaling and cognition","volume":"13","author":"Denver","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.nbd.2023.106229_bb0295","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","article-title":"The P2X7 receptor in infection and inflammation","volume":"47","author":"Di Virgilio","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.nbd.2023.106229_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109333","article-title":"Extracellular ATP: A powerful inflammatory mediator in the central nervous system","volume":"224","author":"Di Virgilio","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2023.106229_bb0305","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1096\/fj.08-122275","article-title":"Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration","volume":"23","author":"D\u00edaz-Hern\u00e1ndez","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2023.106229_bb0310","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.nbd.2007.07.009","article-title":"Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6\/2 Huntington\u2019s disease mice","volume":"28","author":"Domenici","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2023.106229_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104338","article-title":"Adenosine A(2A) receptor as potential therapeutic target in neuropsychiatric disorders","volume":"147","author":"Domenici","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.nbd.2023.106229_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021899","article-title":"Caffeine consumption prevents diabetes-induced memory impairment and synaptotoxicity in the hippocampus of NONcZNO10\/LTJ mice","volume":"7","author":"Duarte","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2023.106229_bb0325","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/glia.23476","article-title":"Region-specific control of microglia by adenosine A(2A) receptors: uncoupling anxiety and associated cognitive deficits in female rats","volume":"67","author":"Duarte","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2023.106229_bb0330","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1124\/mol.107.042077","article-title":"Go it alone no more - P2X7 joins the society of heteromeric ATP-gated receptor channels","volume":"72","author":"Dubyak","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2023.106229_bb0335","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/359144a0","article-title":"ATP receptor-mediated synaptic currents in the central nervous system","volume":"359","author":"Edwards","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2023.106229_bb0340","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1073\/pnas.1614677114","article-title":"Recovery sleep after extended wakefulness restores elevated A(1) adenosine receptor availability in the human brain","volume":"114","author":"Elmenhorst","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2023.106229_bb0345","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.2147\/JIR.S287740","article-title":"Targeting neuroinflammation via purinergic P2 receptors for disease modification in drug-refractory epilepsy","volume":"14","author":"Engel","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.nbd.2023.106229_bb0350","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fnmol.2018.00235","article-title":"Beneficial effect of a selective adenosine A(2A) receptor antagonist in the APPswe\/PS1dE9 mouse model of Alzheimer\u2019s disease","volume":"11","author":"Faivre","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0355","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nbd.2014.08.013","article-title":"Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington\u2019s disease","volume":"71","author":"Ferrante","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2023.106229_bb0360","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41398-021-01238-5","article-title":"Adenosine A(2A) receptor inhibition reduces synaptic and cognitive hippocampal alterations in Fmr1 KO mice","volume":"11","author":"Ferrante","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2023.106229_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109329","article-title":"Presynaptic adenosine receptor heteromers as key modulators of glutamatergic and dopaminergic neurotransmission in the striatum","volume":"223","author":"Ferr\u00e9","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2023.106229_bb0370","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbr.2012.04.015","article-title":"Modulation of the extinction of two different fear-motivated tasks in three distinct brain areas","volume":"232","author":"Fiorenza","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2023.106229_bb0375","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1042\/BST20130229","article-title":"From epidemiology to pathophysiology: what about caffeine in Alzheimer\u2019s disease?","volume":"42","author":"Flaten","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.nbd.2023.106229_bb0380","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fnmol.2020.00094","article-title":"The Role of P2X7 receptor in Alzheimer\u2019s disease","volume":"13","author":"Francistiov\u00e1","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.110.003285","article-title":"International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors - an update","volume":"63","author":"Fredholm","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.nbd.2023.106229_bb0390","doi-asserted-by":"crossref","first-page":"13115","DOI":"10.1038\/s41598-017-13243-0","article-title":"Astrocyte calcium waves propagate proximally by gap junction and distally by extracellular diffusion of ATP released from volume-regulated anion channels","volume":"7","author":"Fujii","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2023.106229_bb0395","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1254\/jphs.12R09CP","article-title":"Roles of dopamine and inflammation-related molecules in behavioral alterations caused by repeated stress","volume":"120","author":"Furuyashiki","year":"2012","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2023.106229_bb0400","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0361-9230(01)00501-9","article-title":"Caffeine reverses the memory disruption induced by intra-nigral MPTP-injection in rats","volume":"55","author":"Gevaerd","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2023.106229_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042380","article-title":"Beyond seizure control: treating comorbidities in epilepsy via targeting of the P2X7 receptor","volume":"23","author":"Gil","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2023.106229_bb0410","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1460-9568.2002.02122.x","article-title":"Mice lacking the adenosine A1 receptor are anxious and aggressive, but are normal learners with reduced muscle strength and survival rate","volume":"16","author":"Gim\u00e9nez-Llort","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0415","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/syn.20146","article-title":"Mice lacking the adenosine A1 receptor have normal spatial learning and plasticity in the CA1 region of the hippocampus, but they habituate more slowly","volume":"57","author":"Gim\u00e9nez-Llort","year":"2005","journal-title":"Synapse (New York, N.Y.)"},{"key":"10.1016\/j.nbd.2023.106229_bb0420","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s12264-020-00582-8","article-title":"Purinergic receptors in basal ganglia diseases: shared molecular mechanisms between Huntington\u2019s and Parkinson\u2019s disease","volume":"36","author":"Glaser","year":"2020","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.nbd.2023.106229_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.659097","article-title":"Antagonistic roles of P2X7 and P2Y2 receptors in neurodegenerative diseases","volume":"12","author":"Glaser","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.nbd.2023.106229_bb0430","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.bbamem.2010.12.001","article-title":"Adenosine receptors and brain diseases: neuroprotection and neurodegeneration","volume":"1808","author":"Gomes","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2023.106229_bb0435","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41583-018-0054-8","article-title":"Rodent models for Alzheimer disease","volume":"19","author":"G\u00f6tz","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0440","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1124\/mol.107.035980","article-title":"Evidence for functional P2X4\/P2X7 heteromeric receptors","volume":"72","author":"Guo","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2023.106229_bb0445","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.neuropharm.2010.05.013","article-title":"P2Y1 receptors inhibit long-term depression in the prefrontal cortex","volume":"59","author":"Guzman","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2023.106229_bb0450","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/nn1997","article-title":"Microglia: active sensor and versatile effector cells in the normal and pathologic brain","volume":"10","author":"Hanisch","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0455","doi-asserted-by":"crossref","first-page":"E3786","DOI":"10.1073\/pnas.1701379114","article-title":"On the permeation of large organic cations through the pore of ATP-gated P2X receptors","volume":"114","author":"Harkat","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2023.106229_bb0460","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1385\/NMM:3:3:173","article-title":"Alzheimer\u2019s amyloid beta-peptide enhances ATP\/gap junction-mediated calcium-wave propagation in astrocytes","volume":"3","author":"Haughey","year":"2003","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.nbd.2023.106229_bb0465","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/cercor\/bhab244","article-title":"\u03b1-Synuclein selectively impairs motor sequence learning and value sensitivity: reversal by the adenosine A2A receptor antagonists","volume":"32","author":"He","year":"2022","journal-title":"Cerebral Cortex (New York, N.Y. : 1991)"},{"key":"10.1016\/j.nbd.2023.106229_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2021.101993","article-title":"The potential of the P2X7 receptor as a therapeutic target in a sub-chronic PCP-induced rodent model of schizophrenia","volume":"116","author":"Huang","year":"2021","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.nbd.2023.106229_bb0475","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1124\/pharmrev.121.000445","article-title":"International union of basic and clinical pharmacology. CXII: adenosine receptors: a further update","volume":"74","author":"IJzerman","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.nbd.2023.106229_bb0480","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/14728222.2019.1575811","article-title":"The P2X7 receptor: a new therapeutic target in Alzheimer\u2019s disease","volume":"23","author":"Illes","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.nbd.2023.106229_bb0485","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3389\/fnmol.2019.00331","article-title":"Pathological ATPergic signaling in major depression and bipolar disorder","volume":"12","author":"Illes","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0490","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051108","article-title":"Regulation of microglial functions by purinergic mechanisms in the healthy and diseased CNS","volume":"9","author":"Illes","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.nbd.2023.106229_bb0495","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/bph.15299","article-title":"Update of P2X receptor properties and their pharmacology: IUPHAR Review 30","volume":"178","author":"Illes","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2023.106229_bb0500","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00213-011-2579-7","article-title":"Reversal learning as a measure of impulsive and compulsive behavior in addictions","volume":"219","author":"Izquierdo","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nbd.2023.106229_bb0505","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.tins.2018.12.007","article-title":"Ion channels and receptors as determinants of microglial function","volume":"42","author":"Izquierdo","year":"2019","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0510","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1111\/bph.15005","article-title":"Update of P2Y receptor pharmacology: IUPHAR Review 27","volume":"177","author":"Jacobson","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2023.106229_bb0515","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00213-013-3289-0","article-title":"The challenges of clinical trials in fragile X syndrome","volume":"231","author":"Jacquemont","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nbd.2023.106229_bb0520","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbr.2017.12.025","article-title":"Understanding the pathophysiology of depression: From monoamines to the neurogenesis hypothesis model - are we there yet?","volume":"341","author":"Jesulola","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2023.106229_bb0525","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3233\/JAD-215611","article-title":"Circulating naturally occurring antibodies to P2RY2 are decreased in Alzheimer's disease","volume":"87","author":"Jian","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2023.106229_bb0530","first-page":"82","article-title":"Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors","volume":"58","author":"Jiang","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2023.106229_bb0535","doi-asserted-by":"crossref","first-page":"9407","DOI":"10.1073\/pnas.161292398","article-title":"Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor","volume":"98","author":"Johansson","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2023.106229_bb0540","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.36217","article-title":"Re-evaluation of neuronal P2X7 expression using novel mouse models and a P2X7-specific nanobody","volume":"7","author":"Kaczmarek-Hajek","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.nbd.2023.106229_bb0545","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00213-013-3158-x","article-title":"Effects of the adenosine A2A antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex","volume":"230","author":"Kadowaki Horita","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nbd.2023.106229_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105684","article-title":"Co-expression patterns of microglia markers Iba1, TMEM119 and P2RY12 in Alzheimer\u2019s disease","volume":"167","author":"Kenkhuis","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2023.106229_bb0555","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1523\/JNEUROSCI.19-17-07289.1999","article-title":"Allosteric control of gating and kinetics at P2X(4) receptor channels","volume":"19","author":"Khakh","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0560","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3389\/fncel.2019.00331","article-title":"Dopamine receptor blockade attenuates purinergic P2X4 receptor-mediated prepulse inhibition deficits and underlying molecular mechanisms","volume":"13","author":"Khoja","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0565","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1600-0447.1961.tb07367.x","article-title":"Pseudo-dementia","volume":"37","author":"Kiloh","year":"1961","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.nbd.2023.106229_bb0570","first-page":"6539","article-title":"Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal \u03b2-catenin pathway function in an Alzheimer\u2019s disease model","volume":"187","author":"Kitazawa","year":"2011","journal-title":"J. Immunol. (Baltimore, Md.\u202f: 1950)"},{"key":"10.1016\/j.nbd.2023.106229_bb0575","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/npp.2014.173","article-title":"Impaired cognition after stimulation of P2Y1 receptors in the rat medial prefrontal cortex","volume":"40","author":"Koch","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2023.106229_bb0580","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/glia.22358","article-title":"Purinergic receptors in microglia: functional modal shifts of microglia mediated by P2 and P1 receptors","volume":"61","author":"Koizumi","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2023.106229_bb0585","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3988\/jcn.2016.12.4.426","article-title":"Clinical Considerations of Obstructive Sleep Apnea with Little REM Sleep","volume":"12","author":"Koo","year":"2016","journal-title":"J. Clin. Neurol. (Seoul, Korea)"},{"key":"10.1016\/j.nbd.2023.106229_bb0590","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/5584_2017_98","article-title":"Structure, pharmacology and roles in physiology of the P2Y(12) receptor","volume":"1051","author":"K\u00fcgelgen","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.nbd.2023.106229_bb0595","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s002100000310","article-title":"Molecular pharmacology of P2Y-receptors","volume":"362","author":"K\u00fcgelgen","year":"2000","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.nbd.2023.106229_bb0600","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006006","article-title":"Impaired interleukin-1beta and c-Fos expression in the hippocampus is associated with a spatial memory deficit in P2X(7) receptor-deficient mice","volume":"4","author":"Labrousse","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2023.106229_bb0605","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer\u2019s disease","volume":"27","author":"Lacor","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0610","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0074-7742(08)00020-2","article-title":"Psychiatric comorbidities in epilepsy","volume":"83","author":"LaFrance","year":"2008","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.nbd.2023.106229_bb0615","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/070674371405901206","article-title":"Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment","volume":"59","author":"Lam","year":"2014","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.nbd.2023.106229_bb0620","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.neurobiolaging.2014.03.027","article-title":"Beneficial effects of caffeine in a transgenic model of Alzheimer\u2019s disease-like tau pathology","volume":"35","author":"Laurent","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2023.106229_bb0625","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/mp.2015.115","article-title":"A2A adenosine receptor deletion is protective in a mouse model of Tauopathy","volume":"21","author":"Laurent","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2023.106229_bb0630","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1352\/0895-8017(2006)111[199:VOTADI]2.0.CO;2","article-title":"Validity of the autism diagnostic interview-revised","volume":"111","author":"Lecavalier","year":"2006","journal-title":"Am. J. Mental Retardation"},{"key":"10.1016\/j.nbd.2023.106229_bb0635","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3858\/emm.2011.43.1.001","article-title":"Microglial P2X\u2087 receptor expression is accompanied by neuronal damage in the cerebral cortex of the APPswe\/PS1dE9 mouse model of Alzheimer\u2019s disease","volume":"43","author":"Lee","year":"2011","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.nbd.2023.106229_bb0640","doi-asserted-by":"crossref","first-page":"8936","DOI":"10.1007\/s12035-018-1030-z","article-title":"Adenosine augmentation evoked by an ENT1 inhibitor improves memory impairment and neuronal plasticity in the APP\/PS1 mouse model of Alzheimer\u2019s disease","volume":"55","author":"Lee","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2023.106229_bb0645","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1523\/JNEUROSCI.0203-11.2011","article-title":"Soluble A\u03b2 oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors","volume":"31","author":"Li","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0650","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1128\/MCB.00544-13","article-title":"P2Y4 receptor-mediated pinocytosis contributes to amyloid beta-induced self-uptake by microglia","volume":"33","author":"Li","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2023.106229_bb0655","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nbd.2015.03.030","article-title":"Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington\u2019s disease models","volume":"79","author":"Li","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2023.106229_bb0660","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.biopsych.2017.07.017","article-title":"The corticostriatal adenosine A(2A) receptor controls maintenance and retrieval of spatial working memory","volume":"83","author":"Li","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2023.106229_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113929","article-title":"Blockade of adenosine A(2A) receptor alleviates cognitive dysfunction after chronic exposure to intermittent hypoxia in mice","volume":"350","author":"Li","year":"2022","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2023.106229_bb0670","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s12264-021-00782-w","article-title":"Entrainment of astrocytic and neuronal Ca(2+) population dynamics during information processing of working memory in mice","volume":"38","author":"Lin","year":"2022","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.nbd.2023.106229_bb0675","first-page":"140","article-title":"Childhood adversities and depression in adulthood: current findings and future directions","volume":"24","author":"Liu","year":"2017","journal-title":"Clin. Psychol."},{"key":"10.1016\/j.nbd.2023.106229_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2022.113664","article-title":"HMGB1-NLRP3-P2X7R pathway participates in PM(2.5)-induced hippocampal neuron impairment by regulating microglia activation","volume":"239","author":"Liu","year":"2022","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.nbd.2023.106229_bb0685","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.666710","article-title":"Astrocytes and adenosine A(2A) receptors: active players in Alzheimer\u2019s disease","volume":"15","author":"Lopes","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0690","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041868","article-title":"Loss of P2Y12 has behavioral effects in the adult mouse","volume":"22","author":"Lowery","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2023.106229_bb0695","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/archinternmed.2011.393","article-title":"Coffee, caffeine, and risk of depression among women","volume":"171","author":"Lucas","year":"2011","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.nbd.2023.106229_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109776","article-title":"Caffeine prevents neurodegeneration and behavioral alterations in a mice model of agitated depression","volume":"98","author":"Machado","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2023.106229_bb0705","doi-asserted-by":"crossref","first-page":"fcab011","DOI":"10.1093\/braincomms\/fcab011","article-title":"Distinct microglial response against Alzheimer's amyloid and tau pathologies characterized by P2Y12 receptor","volume":"3","author":"Maeda","year":"2021","journal-title":"Brain Commun."},{"key":"10.1016\/j.nbd.2023.106229_bb0710","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3233\/JAD-160365","article-title":"Neuritic and diffuse plaque associations with memory in non-cognitively impaired elderly","volume":"53","author":"Malek-Ahmadi","year":"2016","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.nbd.2023.106229_bb0715","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","article-title":"Depression","volume":"392","author":"Malhi","year":"2018","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.nbd.2023.106229_bb0720","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41380-018-0108-3","article-title":"New role of P2X7 receptor in an Alzheimer\u2019s disease mouse model","volume":"24","author":"Martin","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2023.106229_bb0725","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.arbres.2014.06.017","article-title":"Sleep apnea-hypopnea syndrome and type 2 diabetes. A reciprocal relationship?","volume":"51","author":"Mart\u00ednez Cer\u00f3n","year":"2015","journal-title":"Arch. Bronconeumol."},{"key":"10.1016\/j.nbd.2023.106229_bb0730","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3389\/fncel.2019.00143","article-title":"Amyloid peptide induced neuroinflammation increases the P2X7 receptor expression in microglial cells, impacting on its functionality","volume":"13","author":"Mart\u00ednez-Frailes","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0735","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3233\/JAD-2012-120469","article-title":"Astrocytic adenosine A2A receptors control the amyloid-\u03b2 peptide-induced decrease of glutamate uptake","volume":"31","author":"Matos","year":"2012","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.nbd.2023.106229_bb0740","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.biopsych.2015.02.026","article-title":"Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: relevance to schizophrenia","volume":"78","author":"Matos","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2023.106229_bb0745","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1152\/physrev.1997.77.4.1081","article-title":"Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives","volume":"77","author":"Mattson","year":"1997","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2023.106229_bb0750","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1523\/JNEUROSCI.4320-04.2005","article-title":"Deficits in experience-dependent cortical plasticity and sensory-discrimination learning in presymptomatic Huntington\u2019s disease mice","volume":"25","author":"Mazarakis","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0755","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington\u2019s disease: a clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2023.106229_bb0760","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27092680","article-title":"Pathophysiological role and medicinal chemistry of A(2A) adenosine receptor antagonists in Alzheimer's disease","volume":"27","author":"Merighi","year":"2022","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.nbd.2023.106229_bb0765","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/schbul\/sbz086","article-title":"Adenosine kinase expression in the frontal cortex in schizophrenia","volume":"46","author":"Moody","year":"2020","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.nbd.2023.106229_bb0770","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.euroneuro.2016.04.003","article-title":"Genetic blockade of adenosine A2A receptors induces cognitive impairments and anatomical changes related to psychotic symptoms in mice","volume":"26","author":"Moscoso-Castro","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.nbd.2023.106229_bb0775","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuropharm.2017.08.027","article-title":"Cognitive impairments associated with alterations in synaptic proteins induced by the genetic loss of adenosine A(2A) receptors in mice","volume":"126","author":"Moscoso-Castro","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2023.106229_bb0780","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.bbrc.2008.10.042","article-title":"Homotrimeric complexes are the dominant assembly state of native P2X7 subunits","volume":"377","author":"Nicke","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2023.106229_bb0785","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/sj.bjp.0701386","article-title":"Role of ATP in fast excitatory synaptic potentials in locus coeruleus neurones of the rat","volume":"122","author":"Nieber","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2023.106229_bb0790","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.nbd.2023.106229_bb0795","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s002100000311","article-title":"Neuronal P2X receptors: localisation and functional properties","volume":"362","author":"N\u00f6renberg","year":"2000","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.nbd.2023.106229_bb0800","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1152\/physrev.00015.2002","article-title":"Molecular physiology of P2X receptors","volume":"82","author":"North","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2023.106229_bb0805","doi-asserted-by":"crossref","first-page":"8486","DOI":"10.1007\/s12035-018-1000-5","article-title":"Differential behavioral and biochemical responses to caffeine in male and female rats from a validated model of attention deficit and hyperactivity disorder","volume":"55","author":"Nunes","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2023.106229_bb0810","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nbd.2014.08.031","article-title":"Astrocytes and microglia but not neurons preferentially generate N-terminally truncated A\u03b2 peptides","volume":"73","author":"Oberstein","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2023.106229_bb0815","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.567430","article-title":"P2X7 receptor upregulation in Huntington\u2019s disease brains","volume":"13","author":"Oll\u00e0","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0820","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nn.3930","article-title":"Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory","volume":"18","author":"Orr","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0825","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.tins.2013.04.004","article-title":"Emerging role for astroglial networks in information processing: from synapse to behavior","volume":"36","author":"Pannasch","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0830","doi-asserted-by":"crossref","first-page":"948","DOI":"10.2174\/156802611795347582","article-title":"Molecular biology of nucleoside transporters and their distributions and functions in the brain","volume":"11","author":"Parkinson","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.nbd.2023.106229_bb0835","doi-asserted-by":"crossref","first-page":"13309","DOI":"10.1074\/jbc.M209478200","article-title":"P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer\u2019s disease","volume":"278","author":"Parvathenani","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2023.106229_bb0840","doi-asserted-by":"crossref","DOI":"10.1126\/science.abb0556","article-title":"Regulation of sleep homeostasis mediator adenosine by basal forebrain glutamatergic neurons","volume":"369","author":"Peng","year":"2020","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.nbd.2023.106229_bb0845","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2147\/NDT.S199746","article-title":"Cognitive impairment in depression: recent advances and novel treatments","volume":"15","author":"Perini","year":"2019","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.nbd.2023.106229_bb0850","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.2174\/0929867323666161213101126","article-title":"Alzheimer\u2019s disease: a review from the pathophysiology to diagnosis, new perspectives for pharmacological treatment","volume":"25","author":"Picanco","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.nbd.2023.106229_bb0855","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbr.2010.06.022","article-title":"Chronic caffeine treatment during prepubertal period confers long-term cognitive benefits in adult spontaneously hypertensive rats (SHR), an animal model of attention deficit hyperactivity disorder (ADHD)","volume":"215","author":"Pires","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2023.106229_bb0860","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pneurobio.2006.12.005","article-title":"Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington\u2019s disease","volume":"81","author":"Popoli","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2023.106229_bb0865","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0306-4522(00)00220-7","article-title":"Brain site-specificity of extracellular adenosine concentration changes during sleep deprivation and spontaneous sleep: an in vivo microdialysis study","volume":"99","author":"Porkka-Heiskanen","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2023.106229_bb0870","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/01.fbp.0000166825.62130.9a","article-title":"Antagonistic interaction between adenosine A2A and dopamine D2 receptors modulates the social recognition memory in reserpine-treated rats","volume":"16","author":"Prediger","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.nbd.2023.106229_bb0875","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ynstr.2016.10.001","article-title":"Chronic psychosocial stressors in adulthood: Studies in mice, rats and tree shrews","volume":"6","author":"Pryce","year":"2017","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.nbd.2023.106229_bb0880","article-title":"Adenosine A(1) receptor agonist, N6-cyclohexyladenosine, attenuates Huntington\u2019s disease via stimulation of TrKB\/PI3K\/Akt\/CREB\/BDNF pathway in 3-nitropropionic acid rat model","volume":"369","author":"Rabie","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.nbd.2023.106229_bb0885","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2174\/1567205012666150701103107","article-title":"Neurobiology of Alzheimer\u2019s disease: integrated molecular, physiological, anatomical, biomarker, and cognitive dimensions","volume":"12","author":"Raskin","year":"2015","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.nbd.2023.106229_bb0890","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1177\/0269881120914206","article-title":"Characterisation of the pharmacodynamic effects of the P2X7 receptor antagonist JNJ-54175446 using an oral dexamphetamine challenge model in healthy males in a randomised, double-blind, placebo-controlled, multiple ascending dose trial","volume":"34","author":"Recourt","year":"2020","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"key":"10.1016\/j.nbd.2023.106229_bb0895","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1084\/jem.20171487","article-title":"P2Y1 receptor blockade normalizes network dysfunction and cognition in an Alzheimer\u2019s disease model","volume":"215","author":"Reichenbach","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2023.106229_bb0900","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","article-title":"Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers","volume":"88","author":"Reitz","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.nbd.2023.106229_bb0905","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109371","article-title":"Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer's disease","volume":"226","author":"Ribeiro","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2023.106229_bb0910","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0893-133X(97)00033-X","article-title":"Adenosine A2A agonists: a potential new type of atypical antipsychotic","volume":"17","author":"Rimondini","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2023.106229_bb0915","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature09817","article-title":"Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation","volume":"472","author":"Sahay","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2023.106229_bb0920","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1517\/14728222.10.4.515","article-title":"Targeting the dopamine D2 receptor in schizophrenia","volume":"10","author":"Seeman","year":"2006","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.nbd.2023.106229_bb0925","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbr.2012.12.024","article-title":"Deletion of striatal adenosine A(2A) receptor spares latent inhibition and prepulse inhibition but impairs active avoidance learning","volume":"242","author":"Singer","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2023.106229_bb0930","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/5584_2017_59","article-title":"The P2X7 receptor","volume":"1051","author":"Sluyter","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.nbd.2023.106229_bb0935","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.1074\/jbc.REV120.011743","article-title":"The emerging role of \u03b1-synuclein truncation in aggregation and disease","volume":"295","author":"Sorrentino","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2023.106229_bb0940","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tips.2014.08.002","article-title":"P2X7 receptor: an emerging target in central nervous system diseases","volume":"35","author":"Sperl\u00e1gh","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2023.106229_bb0945","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ncl.2020.01.010","article-title":"Medical, surgical, and genetic treatment of Huntington disease","volume":"38","author":"Stahl","year":"2020","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.nbd.2023.106229_bb0950","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22040676","article-title":"Adenosine A1 and A2A receptors in the brain: current research and their role in neurodegeneration","volume":"22","author":"Stockwell","year":"2017","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.nbd.2023.106229_bb0955","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-540-89615-9_17","article-title":"Adenosine receptors and neurological disease: neuroprotection and neurodegeneration","volume":"535\u2013587","author":"Stone","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.nbd.2023.106229_bb0960","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ijnp\/pyab087","article-title":"Prenatal poly I:C challenge affects behaviors and neurotransmission via elevated neuroinflammation responses in female juvenile rats","volume":"25","author":"Su","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.nbd.2023.106229_bb0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109273","article-title":"Accumbal adenosine A(2A) receptor inactivation biases for large and costly rewards in the effort- but not delay-based decision making","volume":"222","author":"Sun","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2023.106229_bb0970","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.272.5262.735","article-title":"The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7)","volume":"272","author":"Surprenant","year":"1996","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.nbd.2023.106229_bb0975","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1037\/0735-7044.112.6.1475","article-title":"Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD)","volume":"112","author":"Szechtman","year":"1998","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0980","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fncel.2018.00323","article-title":"Bidirectional microglia-neuron communication in health and disease","volume":"12","author":"Szepesi","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0985","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.2741\/2870","article-title":"Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies","volume":"13","author":"Takahashi","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.nbd.2023.106229_bb0990","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/s41380-018-0110-9","article-title":"Age-related shift in LTD is dependent on neuronal adenosine A(2A) receptors interplay with mGluR5 and NMDA receptors","volume":"25","author":"Temido-Ferreira","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2023.106229_bb0995","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1523\/JNEUROSCI.23-10-04278.2003","article-title":"A1 receptor and adenosinergic homeostatic regulation of sleep-wakefulness: effects of antisense to the A1 receptor in the cholinergic basal forebrain","volume":"23","author":"Thakkar","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb1000","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.brainres.2012.06.045","article-title":"Connexin-based intercellular communication and astrocyte heterogeneity","volume":"1487","author":"Theis","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2023.106229_bb1005","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1177\/0269881118800067","article-title":"Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants","volume":"32","author":"Timmers","year":"2018","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"key":"10.1016\/j.nbd.2023.106229_bb1010","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1074\/jbc.274.10.6653","article-title":"Hetero-oligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners","volume":"274","author":"Torres","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2023.106229_bb1015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbr.2009.05.006","article-title":"Rule learning, visuospatial function and motor performance in the Hdh(Q92) knock-in mouse model of Huntington\u2019s disease","volume":"203","author":"Trueman","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2023.106229_bb1020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/B978-0-12-801022-8.00008-8","article-title":"Effects of the adenosine A2A receptor antagonist on cognitive dysfunction in Parkinson\u2019s disease","volume":"119","author":"Uchida","year":"2014","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.nbd.2023.106229_bb1025","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1152\/physrev.00042.2016","article-title":"Physiology of Astroglia","volume":"98","author":"Verkhratsky","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2023.106229_bb1030","article-title":"Lecanemab for Alzheimer's disease","volume":"379","author":"Walsh","year":"2022","journal-title":"BMJ (Clin. Res. ed.)"},{"key":"10.1016\/j.nbd.2023.106229_bb1035","doi-asserted-by":"crossref","first-page":"3777351","DOI":"10.1155\/2022\/3777351","article-title":"The improvement of sepsis-associated encephalopathy by P2X7R inhibitor through inhibiting the Omi\/HtrA2 apoptotic signaling pathway","volume":"2022","author":"Wang","year":"2022","journal-title":"Behav. Neurol."},{"key":"10.1016\/j.nbd.2023.106229_bb1040","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/s41467-023-37601-x","article-title":"Lateral septum adenosine A(2A) receptors control stress-induced depressive-like behaviors via signaling to the hypothalamus and habenula","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2023.106229_bb1045","first-page":"313","article-title":"Neuroprotective role of adenosine in the CNS","volume":"54","author":"Wardas","year":"2002","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.nbd.2023.106229_bb1050","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s11302-012-9307-6","article-title":"Neuroprotective roles of the P2Y(2) receptor","volume":"8","author":"Weisman","year":"2012","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.nbd.2023.106229_bb1055","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s11064-014-1271-9","article-title":"Contribution of P2X4 receptors to ethanol intake in male C57BL\/6 mice","volume":"39","author":"Wyatt","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2023.106229_bb1060","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1111\/j.1460-9568.2007.05897.x","article-title":"Transgenic overexpression of adenosine kinase in brain leads to multiple learning impairments and altered sensitivity to psychomimetic drugs","volume":"26","author":"Yee","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb1065","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fchem.2018.00248","article-title":"P2RX7 purinoceptor as a therapeutic target-the second coming?","volume":"6","author":"Young","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.nbd.2023.106229_bb1070","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fncel.2020.00202","article-title":"Neuroprotective effects of adenosine A1 receptor signaling on cognitive impairment induced by chronic intermittent hypoxia in mice","volume":"14","author":"Zhang","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2023.106229_bb1075","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.2174\/1570159X20666220302152400","article-title":"A possible causal involvement of neuroinflammatory, purinergic P2X7 receptors in psychiatric disorders","volume":"20","author":"Zhang","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.nbd.2023.106229_bb1080","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109252","article-title":"Astrocytes and major depression: the purinergic avenue","volume":"220","author":"Zhao","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2023.106229_bb1085","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12458","article-title":"P2Y(12) deficiency in mouse impairs noradrenergic system in brain, and alters anxiety-like neurobehavior and memory","volume":"18","author":"Zheng","year":"2019","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.nbd.2023.106229_bb1090","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fncel.2019.00130","article-title":"Accumbal adenosine A(2A) receptors enhance cognitive flexibility by facilitating strategy shifting","volume":"13","author":"Zhou","year":"2019","journal-title":"Front. Cell. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123002449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123002449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:39:03Z","timestamp":1760852343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996123002449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":218,"alternative-id":["S0969996123002449"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106229","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Purinergic receptors in cognitive disturbances","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106229"}}